|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA08040035
|
14(15)-EpETrE-EA
|
N-((+/-)-14(15)-epoxy-5Z,8Z,11Z-eicosatrienoyl)-ethanolamine
|
NAE 20:4;O
|
C22H37NO3
|
363.277344
|
|
LMFA04000044
|
DPA
|
7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid
|
FA 22:5
|
C22H34O2
|
330.255881
|
|
LMFA02000051
|
13S-HOTrE
|
13S-hydroxy-9Z,11E,15Z-octadecatrienoic acid
|
FA 18:3;O
|
C18H30O3
|
294.219496
|
|
LMFA03000005
|
11R-HEDE
|
11R-hydroxy-12E,14Z-eicosadienoic acid
|
FA 20:2;O
|
C20H36O3
|
324.266446
|
|
LMFA02000052
|
13S-HpOTrE
|
13S-hydroperoxy-9Z,11E,15Z-octadecatrienoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214411
|
|
LMFA03060079
|
11,12-DiHETE
|
(+/-)-11,12-dihydroxy-5Z,8Z,14Z,17Z-eicosatetraenoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA08040036
|
11,12-DiHETrE-EA
|
N-((+/-)-11,12-dihydroxy-5Z,8Z,14Z-eicosatrienoyl)-ethanolamine
|
NAE 20:3;O2
|
C22H39NO4
|
381.287909
|
|
LMFA08040037
|
N-(5Z,8Z,11Z-eicosatrienoyl)-EA
|
N-(5Z,8Z,11Z-eicosatrienoyl)-ethanolamine
|
NAE 20:3
|
C22H39NO2
|
349.298079
|
|
LMFA03030008
|
TXB1
|
9S,11,15S-trihydroxy-thrombox-13E-enoic acid
|
FA 20:2;O4
|
C20H36O6
|
372.251191
|
|
LMFA03030009
|
11-dehydro-TXB3
|
9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E,17Z-trienoic acid
|
FA 20:5;O4
|
C20H30O6
|
366.204241
|
|
LMFA03060084
|
5-HETE
|
5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060085
|
11-HETE
|
11-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060086
|
8-HETE
|
8-hydroxy-5Z,9E,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060087
|
15-HETE
|
15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060088
|
12-HETE
|
12-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA08020072
|
N-arachidonoyl dihydroxypropylamine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-(1,3-dihydroxy-propyl-2-amine)
|
NA 23:4;O2
|
C23H39NO3
|
377.292994
|
|
LMFA03060089
|
9-HETE
|
9-hydroxy-5Z,7E,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA01110001
|
Type IV cyanolipid 20:0 ester
|
(1-cyano-2-methylprop-2-en-1-yl) eicosanoate
|
|
C25H45NO2
|
391.345029
|
|
LMFA04040002
|
15-trans-Neuroprotectin-D1
|
10R,17S-dihydroxy-4Z,7Z,11E,13E,15E,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA00000001
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
FA 40:7;O3
|
C40H66O5
|
626.491026
|
|
LMFA00000004
|
N-linolenoyl-glutamine
|
N-(9Z,12Z,15Z-octadecatrienoyl)-glutamine
|
NAGln 18:3
|
C23H38N2O4
|
406.283158
|
|
LMFA07010004
|
octadecyl 11E-hexadecenoate
|
octadecyl 11E-hexadecenoate
|
WE 34:1
|
C34H66O2
|
506.506281
|
|
LMFA07010005
|
8E-octadecenyl heptadecanoate
|
8E-octadecenyl heptadecanoate
|
WE 36:1
|
C36H70O2
|
534.537581
|
|
LMFA03020031
|
14,15-LTC4
|
15S-hydroxy-14R-(S-glutathionyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C30H47N3O9S
|
625.303303
|
|
LMFA03020032
|
14,15-LTD4
|
15S-hydroxy,14R-(S-cysteinylglycinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C25H40N2O6S
|
496.260709
|
|
LMFA03040003
|
epi-Lipoxin A4
|
5S,6S,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03020033
|
14,15-LTE4
|
15S-hydroxy-14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C23H37NO5S
|
439.239245
|
|
LMFA08020073
|
N-arachidonoyl L-serine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine
|
NASer 20:4
|
C23H37NO4
|
391.272259
|
|
LMFA08020074
|
N-arachidonoyl GABA
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-gamma-aminobutyric acid
|
NA 24:5;O2
|
C24H39NO3
|
389.292994
|
|
LMFA08020075
|
N-arachidonoyl taurine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-taurine
|
NAT 20:4
|
C22H37NO4S
|
411.244330
|
|
LMFA08020076
|
N-arachidonoyl tyrosine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-tyrosine
|
NATyr 20:4
|
C29H41NO4
|
467.303559
|
|
LMFA08020081
|
N-oleoyl taurine
|
N-(9Z-octadecenoyl)-taurine
|
|
C20H39NO4S
|
389.259980
|
|
LMFA08020082
|
N-oleoyl glycine
|
N-(9Z-octadecenoyl)-glycine
|
NAGly 18:1
|
C20H37NO3
|
339.277344
|
|
LMFA03060091
|
17-HETE
|
17-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060092
|
18-HETE
|
18-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA01170063
|
Itaconic acid
|
2-methylenebutanedioic acid
|
FA 5:2;O2
|
C5H6O4
|
130.026610
|
|
LMFA01170065
|
3-maleylpyruvic acid
|
4,6-dioxo-2Z-heptenedioic acid
|
FA 7:4;O4
|
C7H6O6
|
186.016440
|
|
LMFA01170066
|
4-fumarylacetoacetic acid
|
4,6-dioxo-2E-octenedioic acid
|
FA 8:4;O4
|
C8H8O6
|
200.032090
|
|
LMFA01030764
|
cis-parinaric acid
|
9Z,11E,13E,15Z-octadecatetraenoic acid
|
FA 18:4
|
C18H28O2
|
276.208930
|
|
LMFA01030765
|
(5Z,9E,14Z)-icosa-5,9,14-trienoic acid
|
5Z,9E,14Z-eicosatrienoic acid
|
FA 20:3
|
C20H34O2
|
306.255881
|
|
LMFA01030767
|
eicosa-5Z,8Z,14Z-trienoic acid
|
5Z,8Z,14Z-eicosatrienoic acid
|
FA 20:3
|
C20H34O2
|
306.255881
|
|
LMFA03040004
|
Lipoxin C4
|
5S,15S-dihydroxy-6R-(S-glutathionyl)-7E,9E,11Z,13E-eicosatetraenoic acid
|
|
C30H47N3O10S
|
641.298218
|
|
LMFA03040005
|
Lipoxin D4
|
5S,15S-dihydroxy-6R-(S-cysteinylglycinyl)-7E,9E,11Z,13E-eicosatetraenoic acid
|
|
C25H40N2O7S
|
512.255624
|
|
LMFA03040006
|
Lipoxin E4
|
5S,15S-dihydroxy-6R-(S-cysteinyl)-7E,9E,11Z,13E-eicosatetraenoic acid
|
|
C23H37NO6S
|
455.234160
|
|
LMFA01170067
|
fumarylacetic acid
|
4-oxo-2E-hexenedioic acid
|
FA 6:3;O3
|
C6H6O5
|
158.021525
|
|
LMFA01030768
|
cis-dodec-3-enoic acid
|
3Z-dodecenoic acid
|
FA 12:1
|
C12H22O2
|
198.161980
|
|
LMFA01030769
|
cis,cis-dodeca-3,6-dienoic acid
|
3Z,6Z-dodecadienoic acid
|
FA 12:2
|
C12H20O2
|
196.146330
|
|
LMFA01170068
|
3E-methylglutaconic acid
|
3-methyl-2E-pentenedioic acid
|
FA 6:2;O2
|
C6H8O4
|
144.042260
|
|
LMFA01030770
|
cis-tetradec-11-enoic acid
|
11Z-tetradecenoic acid
|
FA 14:1
|
C14H26O2
|
226.193280
|
|
LMFA01030771
|
trans-tetradec-11-enoic acid
|
11E-tetradecenoic acid
|
FA 14:1
|
C14H26O2
|
226.193280
|